Compare TLSA & OTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLSA | OTAI |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United Kingdom | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.4M | 136.6M |
| IPO Year | 2017 | 2026 |
| Metric | TLSA | OTAI |
|---|---|---|
| Price | $0.99 | $10.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 407.6K | 56.9K |
| Earning Date | 05-04-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.87 | $9.90 |
| 52 Week High | $2.53 | $10.73 |
| Indicator | TLSA | OTAI |
|---|---|---|
| Relative Strength Index (RSI) | 44.20 | 57.25 |
| Support Level | $0.87 | $9.92 |
| Resistance Level | $1.45 | $10.04 |
| Average True Range (ATR) | 0.11 | 0.06 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 45.68 | 38.46 |
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.
Starlink AI Acquisition Corp is a blank check company.